- Home
- EMX vs ABSI Comparison
EMX vs ABSI Comparison
Compare EMX & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMX
- ABSI
- Stock Information
- Founded
- EMX N/A
- ABSI 2011
- Country
- EMX Canada
- ABSI United States
- Employees
- EMX N/A
- ABSI N/A
- Industry
- EMX
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- EMX
- ABSI Health Care
- Exchange
- EMX Nasdaq
- ABSI Nasdaq
- Market Cap
- EMX 338.0M
- ABSI 338.0M
- IPO Year
- EMX N/A
- ABSI 2021
- Fundamental
- Price
- EMX $3.65
- ABSI $2.39
- Analyst Decision
- EMX Strong Buy
- ABSI Strong Buy
- Analyst Count
- EMX 2
- ABSI 5
- Target Price
- EMX $5.38
- ABSI $7.98
- AVG Volume (30 Days)
- EMX 447.8K
- ABSI 4.4M
- Earning Date
- EMX 08-11-2025
- ABSI 08-12-2025
- Dividend Yield
- EMX N/A
- ABSI N/A
- EPS Growth
- EMX N/A
- ABSI N/A
- EPS
- EMX 0.04
- ABSI N/A
- Revenue
- EMX $29,864,000.00
- ABSI $4,138,000.00
- Revenue This Year
- EMX $11.08
- ABSI $44.71
- Revenue Next Year
- EMX $3.72
- ABSI $374.26
- P/E Ratio
- EMX $80.97
- ABSI N/A
- Revenue Growth
- EMX N/A
- ABSI 27.32
- 52 Week Low
- EMX $1.59
- ABSI $2.01
- 52 Week High
- EMX $3.66
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- EMX 74.62
- ABSI 33.33
- Support Level
- EMX $3.04
- ABSI $2.50
- Resistance Level
- EMX $3.37
- ABSI $2.73
- Average True Range (ATR)
- EMX 0.12
- ABSI 0.18
- MACD
- EMX 0.03
- ABSI -0.04
- Stochastic Oscillator
- EMX 97.58
- ABSI 1.94
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.